Insider Transactions in Q4 2023 at Talaris Therapeutics, Inc. (TALS)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2023
|
Sandeep Chidambar Kulkarni CEO |
BUY
Open market or private purchase
|
Direct |
4,000
+0.55%
|
$64,000
$16.99 P/Share
|
|
Nov 17
2023
|
Parvinder Thiara Director |
BUY
Open market or private purchase
|
Direct |
1,000
+1.18%
|
$17,000
$17.31 P/Share
|
|
Oct 27
2023
|
Caley Castelein Director |
BUY
Open market or private purchase
|
Direct |
15,800
+2.97%
|
$221,200
$14.55 P/Share
|
|
Oct 26
2023
|
Sandeep Chidambar Kulkarni CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.68%
|
$60,000
$12.25 P/Share
|
|
Oct 25
2023
|
Caley Castelein Director |
BUY
Open market or private purchase
|
Direct |
4,200
+0.83%
|
$50,400
$12.07 P/Share
|
|
Oct 25
2023
|
Parvinder Thiara Director |
BUY
Open market or private purchase
|
Direct |
2,000
+2.36%
|
$24,000
$12.12 P/Share
|
|
Oct 24
2023
|
Sandeep Chidambar Kulkarni CEO |
BUY
Open market or private purchase
|
Direct |
4,650
+0.64%
|
$46,500
$10.68 P/Share
|
|
Oct 24
2023
|
Aaron Kantoff Director |
BUY
Open market or private purchase
|
Direct |
7,500
+14.18%
|
$82,500
$11.86 P/Share
|
|
Oct 24
2023
|
Parvinder Thiara Director |
BUY
Open market or private purchase
|
Direct |
5,000
+5.83%
|
$50,000
$10.66 P/Share
|
|
Oct 19
2023
|
Sapna Srivastava Director |
BUY
Grant, award, or other acquisition
|
Direct |
518
+50.0%
|
-
|
|
Oct 19
2023
|
Parvinder Thiara Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,782
+50.0%
|
-
|
|
Oct 19
2023
|
Sandeep Chidambar Kulkarni CEO |
BUY
Grant, award, or other acquisition
|
Direct |
716,085
+50.0%
|
-
|
|
Oct 19
2023
|
Mark Mcdade Director |
BUY
Grant, award, or other acquisition
|
Direct |
518
+50.0%
|
-
|
|
Oct 19
2023
|
Mark Mcdade Director |
BUY
Grant, award, or other acquisition
|
Indirect |
348,431
+50.0%
|
-
|
|
Oct 19
2023
|
W Bradford Middlekauff CBO, GC and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
69,201
+50.0%
|
-
|
|
Oct 19
2023
|
Caley Castelein Director |
BUY
Grant, award, or other acquisition
|
Indirect |
458,039
+50.0%
|
-
|
|
Oct 19
2023
|
Caley Castelein Director |
BUY
Grant, award, or other acquisition
|
Direct |
496,519
+50.0%
|
-
|
|
Oct 19
2023
|
Yung H. Chyung Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,836
+50.0%
|
-
|
|
Oct 19
2023
|
Kevin Bruce Johnson Chief Regulatory Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,834
+50.0%
|
-
|
|
Oct 19
2023
|
Susan Dana Jones Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,934
+50.0%
|
-
|
|
Oct 19
2023
|
Aaron Kantoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,891
+50.0%
|
-
|